Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

5,727 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A randomised comparison of melphalan with prednisone or dexamethasone as induction therapy and dexamethasone or observation as maintenance therapy in multiple myeloma: NCIC CTG MY.7.
Shustik C, Belch A, Robinson S, Rubin SH, Dolan SP, Kovacs MJ, Grewal KS, Walde D, Barr R, Wilson J, Gill K, Vickars L, Rudinskas L, Sicheri DA, Wilson K, Djurfeldt M, Shepherd LE, Ding K, Meyer RM. Shustik C, et al. Among authors: wilson j, wilson k. Br J Haematol. 2007 Jan;136(2):203-11. doi: 10.1111/j.1365-2141.2006.06405.x. Br J Haematol. 2007. PMID: 17233817 Free article. Clinical Trial.
The VACS index accurately predicts mortality and treatment response among multi-drug resistant HIV infected patients participating in the options in management with antiretrovirals (OPTIMA) study.
Brown ST, Tate JP, Kyriakides TC, Kirkwood KA, Holodniy M, Goulet JL, Angus BJ, Cameron DW, Justice AC; OPTIMA Team. Brown ST, et al. PLoS One. 2014 Mar 25;9(3):e92606. doi: 10.1371/journal.pone.0092606. eCollection 2014. PLoS One. 2014. PMID: 24667813 Free PMC article. Clinical Trial.
Results of antiretroviral treatment interruption and intensification in advanced multi-drug resistant HIV infection from the OPTIMA trial.
Holodniy M, Brown ST, Cameron DW, Kyriakides TC, Angus B, Babiker A, Singer J, Owens DK, Anis A, Goodall R, Hudson F, Piaseczny M, Russo J, Schechter M, Deyton L, Darbyshire J; OPTIMA Team. Holodniy M, et al. PLoS One. 2011 Mar 31;6(3):e14764. doi: 10.1371/journal.pone.0014764. PLoS One. 2011. PMID: 21483491 Free PMC article. Clinical Trial.
Reaction Mechanisms of H2S Oxidation by Naphthoquinones.
Olson KR, Clear KJ, Takata T, Gao Y, Ma Z, Pfaff E, Travlos A, Luu J, Wilson K, Joseph Z, Kyle I, Kasko SM, Jones P Jr, Fukuto J, Xian M, Wu G, Straub KD. Olson KR, et al. Among authors: wilson k. Antioxidants (Basel). 2024 May 20;13(5):619. doi: 10.3390/antiox13050619. Antioxidants (Basel). 2024. PMID: 38790724
Prioritization of Randomized Clinical Trial Questions for Children Hospitalized With Common Conditions: A Consensus Statement.
Coon ER, McDaniel CE, Paciorkowski N, Grimshaw M, Frakes E, Ambroggio L, Auger KA, Cohen E, Garber M, Gill PJ, Jennings R, Joshi NS, Leyenaar JK, McCulloh R, Pantell MS, Sauers-Ford HS, Schroeder AR, Srivastava R, Wang ME, Wilson KM, Kaiser SV; RCT conference series group. Coon ER, et al. Among authors: wilson km. JAMA Netw Open. 2024 May 1;7(5):e2411259. doi: 10.1001/jamanetworkopen.2024.11259. JAMA Netw Open. 2024. PMID: 38748429 Free article.
Correction: Treosulfan compared to busulfan in allogeneic haematopoietic stem cell transplantation for myelofibrosis: a registry-based study from the Chronic Malignancies Working Party of the EBMT.
Robin M, Iacobelli S, Koster L, Passweg J, Avenoso D, Wilson KMO, Salmenniemi U, Dreger P, von dem Borne P, Snowden JA, Robinson S, Finazzi MC, Schroeder T, Collin M, Eder M, Forcade E, Loschi M, Bramanti S, Pérez-Simón JA, Czerw T, Polverelli N, Drozd-Sokolowska J, Raj K, Hernández-Boluda JC, McLornan DP. Robin M, et al. Among authors: wilson kmo. Bone Marrow Transplant. 2024 May 13. doi: 10.1038/s41409-024-02293-4. Online ahead of print. Bone Marrow Transplant. 2024. PMID: 38740952 No abstract available.
5,727 results